Related references
Note: Only part of the references are listed.Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials
Mohamed Alosh et al.
STATISTICS IN MEDICINE (2017)
Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
Ilya Lipkovich et al.
STATISTICS IN MEDICINE (2017)
General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials
Alex Dmitrienko et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2016)
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
Thomas Ondra et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2016)
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Survey Results on Industry Practices and Challenges in Subgroup Analysis in Clinical Trials
Cristiana Mayer et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2015)
Statistical Considerations on Subgroup Analysis in Clinical Trials
Mohamed Alosh et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2015)
BAYESIAN ASSESSMENT OF THE INFLUENCE AND INTERACTION CONDITIONS IN MULTIPOPULATION TAILORING CLINICAL TRIALS
Brian A. Millen et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
RELIABLY BASING CONCLUSIONS ON SUBGROUPS OF RANDOMIZED CLINICAL TRIALS
Armin Koch et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
AN OVERVIEW OF STATISTICAL AND REGULATORY ISSUES IN THE PLANNING, ANALYSIS, AND INTERPRETATION OF SUBGROUP ANALYSES IN CONFIRMATORY CLINICAL TRIALS
Robert Hemmings
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
STRATEGIES FOR IDENTIFYING PREDICTIVE BIOMARKERS AND SUBGROUPS WITH ENHANCED TREATMENT EFFECT IN CLINICAL TRIALS USING SIDES
Ilya Lipkovich et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
A REGULATORY PERSPECTIVE ON ESSENTIAL CONSIDERATIONS IN DESIGN AND ANALYSIS OF SUBGROUPS WHEN CORRECTLY CLASSIFIED
Sue-Jane Wang et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
Multiplicity and replicability: two sides of the same coin
Frank Bretz et al.
PHARMACEUTICAL STATISTICS (2014)
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference Considerations
Brian A. Millen et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2014)
Multiplicity considerations for subgroup analysis subject to consistency constraint
Mohamed Alosh et al.
BIOMETRICAL JOURNAL (2013)
A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research
Ravi Varadhan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Key multiplicity issues in clinical drug development
Alex Dmitrienko et al.
STATISTICS IN MEDICINE (2013)
Extension of adaptive alpha allocation methods for strong control of the family-wise error rate
Haihong Li et al.
STATISTICS IN MEDICINE (2013)
Traditional multiplicity adjustment methods in clinical trials
Alex Dmitrienko et al.
STATISTICS IN MEDICINE (2013)
A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials
Brian A. Millen et al.
DRUG INFORMATION JOURNAL (2012)
Subgroup identification from randomized clinical trial data
Jared C. Foster et al.
STATISTICS IN MEDICINE (2011)
Chain Procedures: A Class of Flexible Closed Testing Procedures With Clinical Trial Applications
Brian A. Millen et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2011)
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
Federico Cappuzzo et al.
LANCET ONCOLOGY (2010)
Design and Analysis Considerations in Clinical Trials With a Sensitive Subpopulation
Yan D. Zhao et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2010)
Some Controversial Multiple Testing Problems in Regulatory Applications
H. M. James Hung et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)
A recycling framework for the construction of Bonferroni-based multiple tests
C. -F. Burman et al.
STATISTICS IN MEDICINE (2009)
A flexible strategy for testing subgroups and overall population
Mohamed Alosh et al.
STATISTICS IN MEDICINE (2009)
A graphical approach to sequentially rejective multiple test procedures
Frank Bretz et al.
STATISTICS IN MEDICINE (2009)
An efficient method for accommodating potentially underpowered primary endpoints
Jianjun (David) Li et al.
STATISTICS IN MEDICINE (2008)
Use of genomic signatures in therapeutics development in oncology and other diseases
R. Simon et al.
PHARMACOGENOMICS JOURNAL (2006)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)